192 related articles for article (PubMed ID: 31335742)
1. Prophylactic octreotide does not reduce the incidence of postoperative chylothorax following lobectomy: Results from a retrospective study.
Zhang C; Zhang H; Wu W; Liu D; Yang D; Zhang M; Lu C
Medicine (Baltimore); 2019 Jul; 98(29):e16599. PubMed ID: 31335742
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic fat-free diet in patients undergoing lobectomy for lung cancer does not decrease postoperative chylothorax: Results from a single-center retrospective study.
Zhang M; Wu W; Li R; Wang M; Yang D; Liu D; Wu Y; Wu Y; Chai N
J BUON; 2020; 25(4):1753-1760. PubMed ID: 33099910
[TBL] [Abstract][Full Text] [Related]
3. Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer.
Takuwa T; Yoshida J; Ono S; Hishida T; Nishimura M; Aokage K; Nagai K
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):571-4. PubMed ID: 23764409
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic ligation of the thoracic duct branch prevents chylothorax after pulmonary resection for right lung cancer.
Liu Z; Du M; Liang Y; Ju S; Li X; Gao Y
Surg Today; 2020 Aug; 50(8):881-888. PubMed ID: 31980933
[TBL] [Abstract][Full Text] [Related]
5. [Late-onset Chylothorax after Right Upper Lobectomy;Report of a Case].
Sakaizawa T; Toishi M; Ozawa K; Nishimura H
Kyobu Geka; 2018 Nov; 71(12):1052-1055. PubMed ID: 30449878
[TBL] [Abstract][Full Text] [Related]
6. Late-onset chylothorax after pulmonary resection for lung cancer.
Tabu M; Imai K; Ogawa J; Minamiya Y; Yoshida S; Hirayama K; Sawano T; Matsuzaki I
Gen Thorac Cardiovasc Surg; 2011 Mar; 59(3):205-8. PubMed ID: 21448802
[TBL] [Abstract][Full Text] [Related]
7. Chylothorax after pulmonary resection and lymph node dissection for primary lung cancer; retrospective observational study.
Yasuura Y; Konno H; Hayakawa T; Terada Y; Mizuno K; Kayata H; Kojima H; Mizuno T; Isaka M; Ohde Y
J Cardiothorac Surg; 2022 Jan; 17(1):11. PubMed ID: 35065672
[TBL] [Abstract][Full Text] [Related]
8. Chyle test is not a valuable laboratory index in identifying chylothorax after pulmonary resection and lymph node dissection for primary non-small cell lung cancer.
Wang H; Gao J; Zhang R; Xie H; Peng Z
J Cancer Res Ther; 2019; 15(2):324-328. PubMed ID: 30964105
[TBL] [Abstract][Full Text] [Related]
9. [The Use of Octreotide Acetate in the Management of Refractory Chylothorax Following Surgical Treatment for Lung Cancer].
Kawakami T; Ishida I; Sugawara T; Oura H
Kyobu Geka; 2016 Jun; 69(6):429-32. PubMed ID: 27246125
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative refractory chylothorax which was improved by octreotide acetate].
Gabe A; Seki M; Taira N; Katsura M; Ishida T; Kang Y; Kubota T; Yamashiro T; Uehara T; Sunagawa T; Ohkubo K
Kyobu Geka; 2012 Mar; 65(3):230-3. PubMed ID: 22374601
[TBL] [Abstract][Full Text] [Related]
11. Late-onset chylothorax during chemotherapy after lobectomy for lung cancer: A case report and review of the literature.
Zhang C; Zhang RM; Pan Y; Wu WB; Zhang M
Medicine (Baltimore); 2019 May; 98(22):e15909. PubMed ID: 31145354
[TBL] [Abstract][Full Text] [Related]
12. The incidence and management of postoperative chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection.
Bryant AS; Minnich DJ; Wei B; Cerfolio RJ
Ann Thorac Surg; 2014 Jul; 98(1):232-5; discussion 235-7. PubMed ID: 24811982
[TBL] [Abstract][Full Text] [Related]
13. Low protein content of drainage fluid is a good predictor for earlier chest tube removal after lobectomy.
Olgac G; Cosgun T; Vayvada M; Ozdemir A; Kutlu CA
Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):650-5. PubMed ID: 24994700
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Chylothorax complicating pulmonary resection with hypertonic glucose Pleurodesis.
Zhang K; Li C; Zhang M; Li Y
J Cardiothorac Surg; 2021 May; 16(1):149. PubMed ID: 34049583
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and predictor of octreotide treatment for postoperative chylothorax after thoracic esophagectomy.
Fujita T; Daiko H
World J Surg; 2014 Aug; 38(8):2039-45. PubMed ID: 24705804
[TBL] [Abstract][Full Text] [Related]
16. Octreotide for treating chylothorax after cardiac surgery.
Kilic D; Sahin E; Gulcan O; Bolat B; Turkoz R; Hatipoglu A
Tex Heart Inst J; 2005; 32(3):437-9. PubMed ID: 16392238
[TBL] [Abstract][Full Text] [Related]
17. Energy devices safety and impact on video-assisted thoracoscopic lung lobectomy postoperative course: monopolar electrocautery versus ultrasonic dissector.
Cattoni M; Rotolo N; Nardecchia E; De Maio S; Dominioni L; Imperatori A
J Cardiothorac Surg; 2021 Mar; 16(1):40. PubMed ID: 33743749
[TBL] [Abstract][Full Text] [Related]
18. Body surface area as a novel risk factor for chylothorax complicating video-assisted thoracoscopic surgery lobectomy for non-small cell lung cancer.
Li S; Wang Y; Zhou K; Cheng S; Wu Y; Che G
Thorac Cancer; 2018 Dec; 9(12):1741-1753. PubMed ID: 30325114
[TBL] [Abstract][Full Text] [Related]
19. Octreotide for management of chylothorax following bidirectional Glenn in a three-month-old infant.
Wright SB; Mainwaring RD
J Card Surg; 2009; 24(2):216-8. PubMed ID: 19267835
[TBL] [Abstract][Full Text] [Related]
20. Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax.
Yin R; Zhang R; Wang J; Yuan L; Hu L; Jiang S; Chen C; Cao Y
Medicine (Baltimore); 2017 Jul; 96(29):e7594. PubMed ID: 28723800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
